Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

AIM Rule 17 and Schedule 2(g) update

20 Mar 2026 07:00

RNS Number : 3767X
Directa Plus PLC
20 March 2026
 

20 March 2026

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

 

AIM Rule 17 and Schedule 2(g) update

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the following information is being disclosed pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

 

Sarah Cope, a Director of Directa Plus, was appointed, and remains, as a Non-Executive Director of Eneraqua Technologies plc ("Eneraqua"), which is not connected to Directa Plus, on 19 August 2021. On 16 March 2026, Eneraqua appointed liquidators to undertake an insolvent Creditors Voluntary Liquidation of Eneraqua.

 

 

For further information, please contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Giorgio Bonfanti, CFO

 

 

Singer Capital Markets (Nominated Adviser and Broker)

+44 20 7496 3069

Rick Thompson / Phil Davies

 

Alma Strategic Communications (Financial PR Adviser)

+44 20 3405 0205

Justine James / Hannah Campbell / Rose Docherty

directaplus@almastrategic.com

 

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus's production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and past

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus's products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKCBQABKDAND
Date   Source Headline
28th May 20267:00 amRNSCancellation - Directa Plus plc
27th Apr 20266:00 pmRNSDirecta Plus
27th Apr 20263:21 pmRNSAppointment of Administrators
14th Apr 20267:00 amRNSUpdate on Funding
13th Apr 20267:43 amRNSUpdate on Further Funding
13th Apr 20267:42 amRNSSuspension - Directa Plus PLC
30th Mar 20267:00 amRNSUpdate on Funding
20th Mar 20267:00 amRNSAIM Rule 17 and Schedule 2(g) update
27th Feb 20267:00 amRNSUpdate on Funding and Board change
7th Jan 20267:00 amRNSFull year trading and operational update
15th Dec 20253:26 pmRNSGrant of 2025 LTIP Awards
24th Sep 20257:00 amRNSHalf Year Report
17th Sep 20257:00 amRNSNotice of interim results presentations
4th Aug 202511:26 amRNSPDMR Dealing
4th Aug 20257:00 amRNSHalf Year Trading Update and Notice of Results
30th Jun 20255:03 pmRNSResult of AGM
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20253:27 pmRNSDirector/PDMR Shareholding
16th Jun 202511:34 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSNotice of Investor Presentation
6th Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
3rd Jun 20257:00 amRNSFinal Results
28th May 20257:00 amRNSNotice of Results
14th Apr 20257:00 amRNSContract Win
7th Apr 20257:00 amRNSTrading and Operational Update & Notice of Results
10th Feb 20257:00 amRNSSetcar secures a new contract win and a renewal
19th Nov 20247:00 amRNSAppointment of Nominated Adviser and Broker
25th Sep 20247:00 amRNSHalf-year Report
13th Sep 20247:00 amRNSNotice of Results
26th Jul 20244:33 pmRNSResult of General Meeting
4th Jul 20242:24 pmRNSNotification of major holdings
2nd Jul 20244:23 pmRNSNotification of major holdings
1st Jul 20243:16 pmRNSNotification of major holdings
28th Jun 20243:09 pmRNSDirectors’ Participation in Fundraising
28th Jun 20242:57 pmRNSHolding(s) in Company
28th Jun 202412:09 pmRNSPosting of Annual Report & Accounts
27th Jun 20243:50 pmRNSResult of AGM & GM
26th Jun 20247:00 amRNSFinal Results
24th Jun 20247:00 amRNSUpdate on Voting & Action to be Taken
12th Jun 20241:06 pmRNSPosting of Circular and Notice of General Meeting
11th Jun 202410:40 amRNSResult of Placing and Subscription
11th Jun 20247:00 amRNSProposed equity raise
3rd Jun 20247:00 amRNSNotice of AGM
29th May 20247:00 amRNSGipave selected for Rome 2025 Jubilee project
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.